Toronto-Dominion Bank »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.8M 6.5M 1.20
2025-06-30 $2.1M 1.6M 1.30
2024-12-31 $3.2M 3.0M 1.06
2023-12-31 $2.3M 2.6M 0.89

More positions owned by Toronto-Dominion Bank

NVIDIA Corporation (NVDA)
eBay (EBAY)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Rbc Cad (RY)
Intel Corporation (INTC)
Micron Technology (MU)
Cibc Cad (CM)
Alphabet Cap Stk Cl A (GOOGL)
Sandisk Corp (SNDK)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)

View all positions for Toronto-Dominion Bank

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Steelhead Partners
Bnp Paribas Arbitrage, Snc
Alberta Investment Management Corporation
DeepCurrents Investment Group
State Street Corporation
Bank of America Corporation
FMR
BlackRock
MacKay Shields
Manufacturers Life Insurance Company
Universal- Beteiligungs- und Servicegesellschaft mbH
Bnp Paribas Investment Partners
CSS
Ameriprise Financial
Toronto-Dominion Bank

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1